Do You Need a Continuous Glucose Monitor If You're Not Diabetic?

A few years ago, the little white disc on someone's upper arm meant one thing: that person has diabetes. Now it might just mean they saw an ad. Continuous glucose monitors are sold over the counter, marketed as wellness devices, and worn by plenty of people whose blood sugar is perfectly normal — often alongside a social feed full of graphs, "spikes," and hacks for flattening them.

It is a genuinely appealing pitch. Instead of guessing whether that bowl of oatmeal works for your body, you get a line on a screen. Real data. Personalized. So the question is fair: if you are not diabetic, are you missing something by not wearing one?

The short answer, based on where the evidence actually stands right now, is no. The longer answer is more interesting, because the reasons why are also a decent map of what does move the needle.

What a CGM Actually Measures

First, a technical point that matters more than it sounds. A continuous glucose monitor does not measure your blood sugar. It measures glucose in the interstitial fluid — the fluid sitting between your cells, just under the skin — and estimates blood glucose from it.

Those two things track each other, but not perfectly and not instantly. Glucose has to diffuse out of the capillaries into that fluid, which introduces a lag, and the relationship shifts with blood flow, temperature, pressure on the sensor, and how fast your glucose is changing. As Professor Javier Gonzalez of the University of Bath put it, CGMs "may be inaccurate because they measure glucose in the fluid surrounding your cells, not directly in your blood."

For someone with type 1 diabetes, that trade is overwhelmingly worth it. A slightly noisy number every five minutes, with trend arrows warning of a drop, beats four fingersticks a day by a mile. For someone with normal glucose trying to decide whether grapes are "bad," the noise is a much bigger share of the signal.

Spikes After Meals Are Not Damage. They Are Digestion.

The central premise of glucose-monitoring wellness content is that a rise in blood sugar after eating is a small injury you should try to prevent. That is not what a postprandial glucose rise is. Eating carbohydrate raises blood glucose; insulin brings it back down; that loop working properly is what a healthy metabolism looks like. A flat line after a meal would be the abnormal result.

We also know roughly what normal looks like on a sensor, because researchers have measured it. A 2019 multicenter study in The Journal of Clinical Endocrinology & Metabolism put CGMs on 153 healthy people without diabetes, ages 7 to 80. Their mean glucose was 99 mg/dL. They spent a median of 96% of the day between 70 and 140 mg/dL, about 2.1% of the day — roughly 30 minutes — above 140 mg/dL, and essentially none of it above 180 mg/dL.

So healthy people do go above 140. Regularly. Every day. If an app colors that segment orange and calls it a spike, it is flagging ordinary human physiology.

It gets murkier still. In a widely cited 2018 PLOS Biology study, Stanford researchers monitored 57 people and found that 24% of those who were normoglycemic by standard blood tests fell into what the authors called a "severe" glucotype — reaching prediabetic glucose levels up to 15% of the recording time and diabetic levels about 2% of the time. The study's authors read that as evidence that "glucose dysregulation, as characterized by CGM, is more prevalent and heterogeneous than previously thought." That is a legitimate finding and worth taking seriously.

But notice what it does not tell you: whether those patterns predict anything about your future health, and whether doing something about them changes your outcome. Nobody has followed those people for twenty years to find out. Which brings us to the actual question.

Does Wearing One Make a Healthy Person Healthier?

This is the part the marketing skips, and it now has a fairly clear answer. In August 2026, JAMA Internal Medicine commissioned a review of the entire evidence base.

That review, by Justin Dower, Minna Johansson, Anne Camp, Victor Montori, and Kasia Lipska, found that in people with type 2 diabetes on glucose-lowering therapy, CGM use was associated with "a modest yet consistent reduction in hemoglobin A1c of approximately 0.3%." Beyond that group, the picture thins out fast: "Only limited and indirect evidence supported the adoption of CGM in people with type 2 diabetes not receiving glucose-lowering therapy or in those with prediabetes or obesity." Their recommendation was that "CGM should be deployed in response to a specific patient problem rather than as a default intervention."

In the companion piece the same authors wrote for patients, they are blunter: "For people without diabetes, there is no good evidence that CGM improves health or prevents diabetes."

Johansson, who is at the University of Gothenburg, added in her university's summary of the work: "I believe that companies marketing this technology should be much more transparent about the fact that there is no evidence that it improves health in people without diabetes."

This is not one contrarian voice. A 2025 systematic review looking specifically at CGM use in non-diabetic people for cardiovascular prevention pooled seven studies covering about 1,127 participants. It found that sensors can act as "a potent motivational feedback mechanism," which is a real point in their favor — but also that "direct evidence on changes in traditional cardiovascular risk factors was limited" and that "evidence of a direct impact on hard cardiovascular endpoints remains limited."

Translation: it might motivate you, the way any tracker might motivate some people. Whether it makes you healthier is an open question nobody has answered.

The Accuracy Problem Nobody Advertises

Even setting outcomes aside — say you just want honest feedback about your food — there is a problem. Researchers at the University of Bath's Centre for Nutrition, Exercise and Metabolism ran a randomized crossover trial, published in The American Journal of Clinical Nutrition, comparing a consumer CGM against finger-prick blood tests in healthy adults eating fruit-based foods.

The sensor did not just add noise. It added bias, in one direction. According to the university's write-up, the CGM overestimated the glycemic index of a smoothie by 30%, reporting it as a medium-GI food (69) when the finger-prick measurement put it in the low-GI range (53). It overestimated time spent above the blood sugar threshold by nearly 400%. Whole fruits that measured as low-GI came out looking medium or high.

The researchers concluded that CGMs are "unlikely to be a valid method to determine whether a food is high or low-GI" in healthy people. Gonzalez's warning is the line worth remembering: "For healthy individuals, relying on CGMs could lead to unnecessary food restrictions or poor dietary choices."

Think about what that means in practice. A device that systematically makes fruit look worse than it is, worn by someone using it to decide what to eat, is not a neutral instrument. If you have ever wondered why glucose-tracking content is so full of people who have concluded that bananas and oats are dangerous, this is a large part of the answer. (Glycemic index has real limits even when it is measured properly — we dug into that in glycemic index vs. glycemic load.)

The Reproducibility Problem That Undercuts "Personalization"

The strongest version of the CGM pitch is not "avoid spikes." It is "discover your personal responses" — the idea that rice might spike you and not your partner, so you can build a diet around your own data.

That claim rests on an assumption: that your response to the same meal is consistent enough to learn anything from. Researchers at the NIH tested it directly. In an inpatient controlled feeding study led by Aaron Hengist and Kevin Hall, 30 adults without diabetes ate meals from rotating menus, then ate the identical meals again about a week later, wearing CGMs throughout.

Agreement between the two runs of the same meal was poor. For the Abbott sensor, the correlation between duplicate meals was r=0.47 with an intraclass correlation of 0.31; for Dexcom, r=0.43 with an ICC of 0.14. The authors titled the paper "Imprecision nutrition?" and concluded: "Individual postprandial CGM responses to duplicate meals were unreliable in adults without diabetes. Personalized diet advice based on CGM measurements in adults without diabetes requires more reliable methods involving aggregated repeated measurements."

In plain terms: eat the exact same lunch twice and the sensor may tell you two different stories. So when you eat a food once, see a rise, and quietly cross it off your list, you may have learned nothing about that food at all. You have learned something about that Tuesday.

The Cost You Cannot See on the Graph

Then there is the psychological side, which the manufacturers themselves are quietly aware of. Abbott's Lingo site tells users to "consult your healthcare professional before making changes to your diet or exercise regime or if you have an eating disorder or a history of eating disorders." That warning is not there by accident.

A device that turns every meal into a pass-or-fail score, refreshed every few minutes on your phone, is a powerful engine for food anxiety. The JAMA Internal Medicine authors flagged exactly this: normal blood glucose fluctuations "can easily be overinterpreted, potentially leading to unnecessary and unhealthy dietary restrictions or anxiety," and using a CGM to avoid spikes "may lead people to unnecessarily restrict healthy foods (such as fresh fruit) or replace them with less healthy options."

That last clause is the real risk. Nobody swaps an apple for broccoli. They swap it for something with fat and protein bolted on that flattens the curve while being nutritionally worse. The graph improves. The diet does not.

And it is not cheap to end up feeling worse about your food. Stelo runs $89 a month on subscription; Lingo's two-week starter sensor is $54. Wear one continuously for a year and you are looking at roughly a thousand dollars — for data that, as things stand, has no demonstrated effect on your health if you do not have diabetes.

When a CGM Genuinely Does Make Sense

None of this makes the technology a gimmick. It is one of the most valuable tools in diabetes care, and the case for it is strong and specific:

• Diabetes, especially insulin-treated. This is what the devices are for, and where the evidence is solid. Johansson's own framing: "This technology is tremendously valuable for certain groups of patients."
• Type 2 diabetes on glucose-lowering therapy. That consistent 0.3% HbA1c improvement is a real, if modest, benefit.
• Prediabetes, with a clinician involved. More than 1 in 3 US adults — 97.6 million people — had prediabetes as of 2021, and most have no idea. That is a genuine public health problem. But prediabetes is found by a cheap A1c or fasting glucose test, not by a sensor, and the JAMA review found only "limited and indirect" evidence for CGM in this group. If your labs are off, the sensor is optional; the follow-up is not.
• Research. Aggregated across many people and many repeated meals, CGM data is scientifically valuable even where any one person's readings are not.
• A short, well-framed experiment. If you are curious, two weeks spent noticing how a big pasta dinner compares to a big salad is a reasonable thing to be curious about. Just go in knowing the numbers are biased upward, that they will not replicate, and that nothing you see is a diagnosis.

What the evidence does not support is the default case: a healthy person wearing one indefinitely, subscription auto-renewing, adjusting their diet meal by meal to a line on a screen.

What Actually Flattens the Curve, No Sensor Required

Here is the slightly deflating punchline. Nearly everything that reliably improves post-meal glucose is something you already know you should do, and you can do all of it without buying anything.

Eat more fiber. The 2019 Lancet series on carbohydrate quality pooled 185 observational studies covering roughly 135 million person-years plus 58 clinical trials. People eating the most fiber versus the least had a 16 to 24% lower incidence of coronary heart disease, stroke, type 2 diabetes, and colorectal cancer, and a 15 to 30% lower risk of all-cause and cardiovascular mortality. The benefit was greatest between 25 and 29 grams a day, with signs that more helps further. No consumer glucose sensor has evidence remotely in this league.

Walk after you eat, not before. A 2023 Sports Medicine meta-analysis of 8 randomized trials found post-meal exercise clearly beat pre-meal exercise for blunting the glucose rise, and that sooner was better than later. Their summary: "Exercise (such as 20 min of walking) has an acute beneficial impact on postprandial hyperglycemia when undertaken as soon as possible after a meal." You may not even need 20 minutes. A separate Sports Medicine meta-analysis of 7 studies found that breaking up prolonged sitting with light walking — bouts as short as 2 minutes every 20 minutes — meaningfully reduced both post-meal glucose (a standardized difference of 0.72, 95% CI 0.41 to 1.03) and insulin, and beat simply standing up.

Change the order. A systematic review in Clinical Nutrition Research covering six studies in 107 healthy adults found that eating vegetables, fruit, or protein before the carbohydrate part of a meal lowered post-meal glucose compared with eating carbs first or everything mixed together. Worth knowing — and worth the honest caveat the authors give themselves: these were short-term acute measurements in mostly young, healthy participants, "making it difficult to extrapolate the findings to long-term glycemic control." We went deeper on this in the order you eat your food in.

Sleep. In a randomized crossover study published in Annals of Internal Medicine, healthy young adults who slept 4.5 hours a night for four nights saw their total-body insulin response fall by an average of 16%, with fat cell insulin sensitivity down 30% — a change the researchers likened to "taking the fat cell functioning of a healthy person down to that of an obese or diabetic patient." Four nights. No change to their diet at all.

Notice something about that list: every item on it is worth doing for reasons that have nothing to do with glucose. Fiber feeds your gut microbiome. A walk after dinner is good for your heart and your mood. Sleep affects everything. You would want all of it even if blood sugar did not exist as a concept — which is roughly the difference between a health habit and a metric to optimize.

Build the Habits Instead of Buying the Hardware

The awkward thing about the fundamentals is that they are not hard to understand. They are hard to actually do on a Wednesday at 6 p.m. when nothing is planned and there is not much in the fridge. That is the real problem, and a thousand dollars of sensors does not solve it. Knowing that fiber matters does not put fiber on your plate.

That gap is what Eat Well Planner is built to close. Every recipe gets a Nutrition Score and plain-language "good source of" highlights, so you can see whether a meal actually delivers fiber before you cook it, rather than inferring it from a graph afterward. Make It Healthier proposes specific ingredient changes and runs each one through a calculator to verify the nutritional gain before showing it to you — so a swap that adds 4 grams of fiber is described as adding 4 grams of fiber, not as a vibe. The Recipe Playground lets you tweak ingredients and watch the score move with each edit, which is the "see the effect of a change" experience people want from a CGM, except measured against actual nutrient data instead of interstitial fluid.

For the rest of it: AI meal planning builds a balanced week out of recipes you already like, auto-generated shopping lists mean the ingredients are in the house when you need them, and Plant Points tracks how many different plants you have eaten this week against the 30-plants-a-week target from microbiome research. That last one is the tracker actually worth having: it counts something you can directly act on, and it pushes you toward more fiber and more variety instead of toward eliminating fruit.

The Bottom Line

If you have diabetes, a CGM may be one of the best tools available to you. If you do not, the honest state of the evidence is that nobody has shown it will make you healthier, the readings run high in healthy people, your own responses do not reliably repeat from one week to the next, and the most likely behavioral outcome is that you eat less fruit and worry more.

The things that genuinely smooth your blood sugar are fiber, whole foods, sensible meal composition, a short walk after dinner, and enough sleep. They are unglamorous, they do not come with a dashboard, and they work whether or not anyone is watching the graph.

Spend the thousand dollars on groceries.